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Abstract: Loss-of-function mutations in the potassium-chloride 
cotransporter KCC3 lead to Andermann syndrome, a severe sensorimotor 
neuropathy characterized by areflexia, amyotrophy and locomotor 
abnormalities. The molecular events responsible for axonal loss remain 
poorly understood. Here, we establish that global or neuron-specific KCC3 
loss-of-function in mice leads to early neuromuscular junction (NMJ) 
abnormalities and muscular atrophy that are consistent with the pre-
synaptic neurotransmission defects observed in patients. KCC3 depletion 
does not modify chloride handling, but promotes an abnormal electrical 
activity among primary motoneurons and mislocalization of Na+/K+-ATPase 
α1 in spinal cord motoneurons. Moreover, the activity-targeting drug 
carbamazepine restores Na+/K+-ATPase α1 localization and reduces NMJ 
denervation in Slc12a6-/- mice. We here propose that abnormal motoneuron 
electrical activity contributes to the peripheral neuropathy observed in 
Andermann syndrome. 
 
 
 
 
Dear Editor 
Thank you for your interest in this study. We have answered to all the points addressed by the 
Referees. 
We now provide discussion and references concerning the pertinence of using motoneuron 
primary culture relative to recordings from post-natal or adult spinal cord slices. We add 
supplemental data in Figure 7 in which we show the change in staining pattern of the NaK 
ATPase 1 subunit pump in P30 spinal cord motoneurons. Figures were modified as 
recommended.  
 
 
Cover Letter
We thank the reviewers for their constructive comments. Our answers to specific points 
are highlighted in yellow. 
 
Reviewers' comments: 
 
Reviewer #1: Andermann syndrome, an autosomal recessive neurodevelopmental and 
neurodegenerative disorder, is caused by mutations within the cation-chloride 
cotransporter KCC3. The typical sensorimotor histophysiopathology of the Adermann 
syndrome is also reproduced in KCC3-deficient mice (Slc12a6-/-). 
In the present manuscript the authors intend to investigate the potential impact of KCC3 
loss-of-function on NMJ integrity, which has never been explored before, and which could 
also account for early motor defects. 
Following an immunohistochemical comparison between WT and Slc12a6-/- mice, the 
Authors show that 
1) Loss of KCC3 results in aberrant pre-synaptic neuromuscular junction terminals; 
2) Neuronal-specific KCC3 deletion results in muscle atrophy and aberrant post-synaptic 
neuromuscular junction terminals. 
These data, together with the observation that patients with Andermann syndrome do not 
display neuromuscular transmission defects, support Authors' conclusion about the 
contribution of a neuronal and KCC3 specific origin for NMJ defects and amyotrophy in 
both murine models of Andermann syndrome and in humans. 
 
Major point 
 
My concern arises when the Authors try to determine the mechanism by means of which 
KCC3 loss-of-function might affect the observed pre-synaptic dependent defects, 
proposing that the peripheral neuropathy found in Slc12a6-/- mouse and, probably, in 
Andermann syndrome is due to an abnormal intrinsic motoneuron electrical activity. 
The point is that the authors perform the whole electrophysiological analysis on in vitro 
cultured neurons, obtain from embryos, claiming that 7-8 DIV is an in vitro timepoint at 
which motoneuron cultures reach electrical maturation.  
I am not sure that motoneuron electrical activity monitored for instance at P30 is 
comparable to that measured in cultured neurons at 7 DIV. For instance, the spike 
frequency/ stimulus plot shown in figure 5E is not distinctive of mature 
motoneurons, that typically show a greater secondary gain at higher injected 
currents. Indeed, dramatic changes in motoneuron electrical activity have been 
widely documented during development and transition from an embryonic to an 
adult stage. 
*Response to Reviews
 We agree with your remark and we also questioned about the values of frequency 
we got in primary cultures. Actually, we cannot record secondary range frequency 
in these primary cultures due to the absence of synaptic inputs from descending 
neurons. What we show corresponds to a primary range which mainly reflects 
intrinsic, not synaptically-regulated firing frequency. This is now stated in results 
p.17 and we now provide a discussion on the electrical properties of primary 
motoneurons vs in situ P8-P15 and P30 spinal cord slice recordings p. 23.  
For these reasons I believe that the Authors should check, at least in part, which 
pattern of electrical activity is detectable in motoneurons from adult animals and 
whether it matches with what they observed in vitro. This could be accomplished by 
performing some electrophysiological experiments using P30 spinal chord slices. 
Only in this way they can be sure that the data they obtained starting from 
embryonic cell cultures can be extrapolated to adult animals and therefore to be an 
explanation for what they reported in the first part of the work. 
Although the advantage of primary culture is to record a true intrinsic motoneuron 
activity, we agree that we cannot fully extrapolate to adult mainly due to the loss of 
extrinsic factors (see new discussion p. 23). This was initially briefly discussed at 
the end of the discussion (effects of proprioceptive inputs on phenotype). 
Motoneurons recordings in P30 spinal cord slices are a well-known difficult matter 
due to their high sensitivity to injury. However, as requested by reviewer 2, we 
added new data showing a change in Na/K ATPase 1 subunit intensity in P30 
spinal cords which, indirectly, supports the role of electrical activity in adult mice 
(Figure 7 F-E and results p. 20 and discussion p. 24). 
 
 
Minor comments 
 
1) 1) Authors should make sure that TEA-Cl completely dissociates at the 
extracellular concentration of 140 mM, otherwise the extracellular [Cl] of 147 mM 
they introduced in Nernst equation is incorrect (p. 6, "Electrophysiological 
recordings", row 9); 
 Solubility of TEA-Cl in water is 50 g/L. At 140 mM, we use 23.2 g/L, thus we think 
that TEA-Cl is completely dissociated in our solution.  
 
2) P. 25 row 5 from bottom: "NMJs of Slc12a6-/- mice are smaller than Slc12a6+/+ 
mice": how much smaller? Please write the numerical values for Mean ± SEM;  
 
3) P. 25 row 3 from bottom: "a greater proportion": how much greater? Please write 
the numerical values for Mean ± SEM;. 
4) In general: please indicate Mean±SEM in the legends of all figs;  
Mean ± SEM are now indicated in all figure legends 
 
5) Please represent the axis of abscissas in the plot of fig 4F as voltage; corrected  
 
6) Legend to fig 5G: please indicate the total sample number. Corrected 
 
 
 
 
 
Reviewer #2: The article entitled «KCC3 loss of function induces activity-dependent 
neuromuscular junction defects" by Melissa Bowerman and collaborators is a convincing 
study showing early pre- and postsynaptic NMJ deficits accompanying skeletal myofiber 
atrophy in young Slc12a6-/- mice (KCC3 KO mice). This study is based on a large variety 
of technics including in vitro perforated patch-clamp electrophysiological recordings from 
cultured spinal MNs (1 and 7 DIV), extracellular recordings, qPCR, IHC combined to 
confocal and electron microscopy and muscle recordings from ACCPN patients (agenesis 
of the corpus callosum with peripheral neuropathy) linked to mutations of KCC3. The 
manuscript is clearly written and deserves to be published in the journal Neurobiology of 
Disease. I appreciate the use of the neuron-specific nsSlc12a6Δ18/Δ18 mouse allowing 
the authors to demonstrate that a KCC3 defect in neuron is sufficient to induce muscle 
atrophy and aberrant post-synaptic neuromuscular junction terminals. 
Data are collected from experiments performed from acute mouse spinal cords (WT or, 
Slc12a6-/-, nsSlc12aΔ18/Δ18) at different developmental stages (P1, P30) or from MNs 
maintained in culture during 1 day or 7-8 days (1 DIV, 7-8 DIV) starting at E12.5. This is 
one of the criticisms that I make about the manuscript. 
The authors should better argue about the stages chosen to perform their 
experiments. For instance the aberrant pre-synaptic neuromuscular junction 
terminals is established at P30 in the Slc12a6-/- mouse whereas the lack of change 
in the chloride homeostasis comes from MNs maintained in primary culture during 
1-7 days from E12.5, i.e., corresponding to P0 not P30.  
First we needed to isolate motoneuron to ensure cell specific changes and we also 
wanted to compare NKCC1 and KCC2 transcripts with functional 
electrophysiological data. The easiest way to combine these experiments was to 
perform primary cultures. Second, using mice E12.5 embryos allows being before 
the programmed death, which ensure obtaining enough material for combining 
transcriptomic analysis to electrophysiological measurements. This sentence is 
added to results p.16. 
It is surprising to observe a reduction in the KCC2 mRNA expression in the 7DIV 
MNs but no change in EGABA. 
We agree with this remark and that is why we performed gramicidin experiments to 
assess a potential functional effect. It is reported that post-transcriptionnal 
modification (phosphorylation of KCC2) is probably more important for KCC2 
activity than a small transcript variation. We think that despite this transcriptional 
change, this is not a limiting step for KCC2 activity. This is now discussed p. 22. 
 Did the authors test EGABA in 30DIV MNs? Maybe it is not possible. 
It is difficult to maintain for a long time (> 15 days) motoneurons in primary 
cultures. So it is why we did not try to measure EGABA at later in vitro stages. We 
choosed to analyze when they are electrically mature, i.e. around 7 DIV.  
 
The link between the beneficial effect of CBZ and the putative impact of the KCC3 
mutation on the NKA that could induce the observed hyperexcitability of the MNs, 
i.e., of the NMJ is not proven. Of course this is a further step but the authors could 
have test whether the localisation / intensity of the NKA is modified in the Slc12a6-/- 
mouse and before and after the in vivo CBZ treatment.  
Indeed, we tested the expression of NKA 1 isoform in WT and Slc12a6-/- in P30 
ventral horn motoneurons. We focussed on the NKA 1 isoform as it is expressed 
in the large  motoneurons responsible for muscle contraction and as initially 
discussed is functionally linked to KCC3. We found an uneven distribution at the 
plasma membrane in KCC3 deleted motoneurons. Staining of NKA 3 isoform was 
more difficult to analyze and did not give different results between WT and Slc12a6-
/- motoneurons. Interestingly, CBZ is able to restore the NKA1 distribution. These 
new data are added in Figure 7E, F, results p. 20 and discussion p. 24.  
 
I think that the Andermann syndrome related to a KCC3 loss should appear in the 
title. We added to title “….contributes to Andermann syndrome by inducing..” 
 
 
 Minor points: 
1. Figure 1: the limit between TCS and T is not clear in panel E. Could the authors 
highlight the 3 processes with different colours?  
We highlighted the nerve terminal which allows to better evidence the 3 
compartments and the decrease in terminal area in KCC3-/- mice.  
 
2. Is a 2 minutes ouabain treatment long enough to observe a shift of plateau 
potential?  
The problem we faced was not the time of ouabain application, but rather the 
concentration. As ouabain is an NKA inhibitor, we tried to find a concentration that 
allowed seeing an electrogenic effect without going to full depolarization and ionic 
disturbance despite our whole-cell recordings conditions. 
3. What means "isolated motoneurons" (page 17)? What is the stage tested?  
 
We removed “isolated” and add 7 DIV Hb9:GFP motoneurons isolated from ventral 
horn without purification steps which allows recordings of a synaptically-driven 
spontaneous activity p. 19. 
4. Please better state the stage when experiments have been performed on the 
nsSlc12aΔ18/Δ18 (page 11)? They were 8-week old. We added this information p.13. 
 
5. Page 12: please better present the results from healthy, myasthenia gravis and 
ACCPN patients allowing to reach the conclusion of neuronal and KCC3 isoform 
origin for KCC3-induced NMJ defect and amyotrophy in both the murine models of 
Andermann syndrome and ACCPN patients. This part of the result data is not clear 
to me.  
We rewrote this part of results p. 13. 
 
6. Page 13: Why the authors use E12.5 as a reference stage to analyse the KCC2 
and NKCC1 transcripts?  
At E12.5, intracellular Cl- is high and excitatory which allows evaluating the chloride 
switch during development. We added a sentence and a reference in results p.15. 
 
7. Page 14: It is difficult to compare 20% change in KCC2 and NKCC1 between E12.5 
and P1 and a 2% change between 1DIV and 7DIV. Does it mean that MN in primary 
culture develop more slowly than in vivo?  
We now discuss this point p.22. 
 
8. Page 15: the authors performed difficult experiments nicely illustrating the 
evolution of EGABA in 1DIV and 7DIV MNs. They conclude that EGABA is not 
significantly different between WT and Slc12a6-/-. But the authors do not present 
the resting membrane potential (rmp) of MNs tested. Could the authors mention the 
rmp and speak about driving force (DV)?  
Our recording conditions for EGABA does not allow for rmp measurements (K+, 
Na+ and Ca2+ currents are inhibited). However, from the analysis of electrical 
activity, we measured RMP values which are clearly more depolarized than EGABA 
at 7DIV. We provide a discussion about driving force p. 22. 
 
9. Figure 3: Please present CAP with the same scale bars. The table does not 
present data from healthy patients.  
The scale bars are modified. For clarity, we added in legend the CAP amplitude and 
age of 3 healthy patients. 
 
10. Figure 4: did the authors measure the mRNA changes for KCC2 and NKCC1 in 
1DIV MNs? This could allow comparing with 7DIV. 
We did and found no significant changes. We added these data in legend of Figure 
4. 
 Again; I am surprise to see the KCC2 reduction in Slc12a6-/- MNs (at 7DIV) but no 
change in EGABAAR.  
See discussion p. 22. 
 
11. Figure 5: better explain what is the PTH. I guess this corresponds to the peak 
AHP value measure on the 12th AP of the AP train? 
Yes. We better explain in Legend Figure 5 
 About the number of APs, in the panel F, on can see only 12 Aps whereas panel D 
illustrates a 15 APs train. 
Mean action potential number at this current amplitude is 10. The first AP is not 
included in counting. We now give in legend of Figure 5, mean AP number and 
importantly the range. The illustration is the upper level of the range and it was not 
possible to perform statistics with 1 or 2 points, it is why the y-scale shows 11 AP, 
not 14. 
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Abstract 
Loss-of-function mutations in the potassium-chloride cotransporter KCC3 lead to Andermann 
syndrome, a severe sensorimotor neuropathy characterized by areflexia, amyotrophy and 
locomotor abnormalities. The molecular events responsible for axonal loss remain poorly 
understood. Here, we establish that global or neuron-specific KCC3 loss-of-function in mice 
leads to early neuromuscular junction (NMJ) abnormalities and muscular atrophy that are 
consistent with the pre-synaptic neurotransmission defects observed in patients. KCC3 
depletion does not modify chloride handling, but promotes an abnormal electrical activity 
among primary motoneurons and mislocalization of Na
+
/K
+
-ATPase α1 in spinal cord 
motoneurons. Moreover, the activity-targeting drug carbamazepine restores Na
+
/K
+
-ATPase 
α1 localization and reduces NMJ denervation in Slc12a6-/- mice. We here propose that 
abnormal motoneuron electrical activity contributes to the peripheral neuropathy observed in 
Andermann syndrome. 
 
Keywords 
Motoneuron, Andermann syndrome, chloride homeostasis, electrical activity, neuromuscular 
junction, Na
+
/K
+
 ATPase  
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Highlights 
1. Neuromuscular junction denervation is an early hallmark of KCC3-deleted mice 
2. KCC3 does not contribute to motoneuron resting chloride handling  
3. KCC3 is involved in motoneuron plateau potential during firing 
4. KCC3 loss of function induces Na
+
/K
+
 ATPase 1 subunit mislocalization 
5. Targeting electrical activity in vivo reduces neuromuscular junction denervation and 
restores Na
+
/K
+
 ATPase 1 membrane pattern in KCC3-deleted mice 
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Introduction 
Andermann syndrome is an autosomal recessive neurodevelopmental and neurodegenerative 
disorder characterized by peripheral neuropathy with variable agenesis of the corpus callosum 
(ACCPN) (Larbrisseau et al., 1984; Mathieu et al., 1990), hypotonia and amyotrophy 
(DeBraekeleer et al., 1993) and is caused by mutations within the cation-chloride 
cotransporter KCC3 (Howard et al., 2002). 
KCC3-deficient mice reproduce the typical ACCPN sensorimotor histophysiopathology, 
displaying impaired locomotor and sensorimotor gating capacities and decreased peripheral 
nerve conduction (Howard et al., 2002; Boettger et al., 2003; Sun et al., 2010; Shekarabi et 
al., 2012). Axonal swelling, neurodegeneration and hypomyelination of the sciatic nerve seem 
to account for the peripheral neuropathy. Both enveloping glial cells and demyelinating events 
have been proposed as the primary events responsible for reduced nerve conduction and 
neurodegeneration in mice and patients (Howard et al., 2002; Dupre et al., 2003; Sun et al., 
2010). However, neuron-specific KCC3 deletion in mice is sufficient to induce peripheral 
neuropathy, supporting a neuronal-dependent neuropathy (Shekarabi et al., 2012) 
KCC3 belongs to the family of cation-chloride cotransporters coded by the Slc12a genes 
(Mount et al., 1999). The Slc12a gene family comprises seven members coding for two 
inwardly directed Na
+
-K
+
-2Cl
-
 cotransporters (Slc12a2 for ubiquitous NKCC1 and Slc12a1 
for kidney specific NKCC2), one Na
+
-Cl
-
 cotransporter (Slc12a3 for kidney specific NCC) 
and four outwardly directed K
+
-Cl
-
 cotransporters, (Slc12a4-7 for KCC1-4, respectively) 
(Gagnon and Delpire, 2013). These membrane proteins are responsible for a wide variety of 
functions including cell volume regulation (O'Neill, 1999) and maintenance of intracellular 
chloride concentration [Cl
-
]i (Blaesse et al., 2009). Following an osmotic challenge, KCCs 
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extrude K
+
 and Cl
-
 ions together with water. Concordantly, axon swelling and periaxonal fluid 
accumulation are observed early in postnatal day (P)3, P8 and P30 KCC3-depleted (Slc12a6
-/-
) mice followed by axonal loss in 7-8 month old adult mice (Byun and Delpire, 2007). As 
younger P30 mice perform poorly motor tests without any apparent axonal degeneration, it is 
assumed that defects in volume regulation are major contributor to impaired motor and 
balance functions (Howard et al., 2002; Byun and Delpire, 2007). However, the potential 
impact of KCC3 loss-of-function on neuromuscular junction (NMJ) integrity, which could 
also account for early motor defects, has never been explored, nor have activity-dependent 
effects of KCC3 through its potential control on neuronal intracellular Cl
-
 and K
+
 content 
(Boettger et al., 2003; Lucas et al., 2012). 
Here, we show that axon denervation occurs at the NMJ in P30 Slc12a6
-/-
 mice, therefore 
representing an early sign of the peripheral neuropathy. We further demonstrate that KCC3 
loss-of-function does not modify the developmental chloride shift observed in spinal cord and 
isolated motoneurons. Instead, Slc12a6
-/-
 motoneurons display an abnormal electrical activity, 
a possible consequence of an unbalanced ionic homeostasis during firing behaviour related to 
Na
+
/K
+
-ATPase dysfunction. Consistent with this proposed detrimental role on electrical 
activity, we found that a pharmacological decrease of motoneuron activity in vivo ameliorated 
NMJ innervation of Slc12a6
-/-
 mice. Combined with the functional analysis of nerve-evoked 
muscle contraction in ACCPN patients, our results highlight pre-synaptic-dependent defects 
as playing a central part of the Andermann syndrome and identify a novel mechanism by 
which loss of KCC3 leads to motor symptoms in this neurodevelopmental disorder. 
 
Material and methods 
Animals  
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All animal experiments were approved by the national ethics committee on animal 
experimentation, and were done in compliance with the European community and national 
directives for the care and use of laboratory animals. Slc12a6
+/-
 mice, described in (Howard et 
al., 2002) were maintained on a C57BL/6 background and we used the offspring of crosses 
between heterozygotes. For experiments using nsSlc12a
∆18/∆18 
mice, described in (Shekarabi et 
al, 2012), we used tissues collected at McGill University. 
For in vivo experiments, carbamazepine (CBZ) or vehicle was administered to P10 Slc12a6
-/-
 
mice by intraperitoneal injection of 0.025 mg/g/day for 20 consecutive days as described in 
(Li et al., 2013). P30 mice were then euthanized and muscles processed for neuromuscular 
junction analysis. A stock solution was prepared at 2.5 mg/ml using 12.5 mg CBZ (Santa-
Cruz Biotechnology) diluted with 5 ml 2-Hydroxypropyl-β-cyclodextrin (Santa-Cruz 
Biotechnology) and stored at +4°C. 
Motoneuron culture 
Genotyping was carried out by PCR on tail DNA of E12.5 embryos obtained from Slc12a6
+/-
 
mice breeding. Embryos were kept at 4°C in Hibernate-E medium (Life technologies) during 
the course of genotyping. Afterwards, Slc12a6
+/+ 
and Slc12a6
-/- 
embryos were processed for 
cultures as described previously (Raoul et al., 2002). Briefly, cells were dissociated 
mechanically after trypsin treatment of the dissected spinal cords. The largest cells were 
isolated using iodixanol density gradient purification. To get highly purified motoneuron 
cultures, we added an immunopurification step using magnetic cell sorting technology (Arce 
et al., 1999). In experiments using Hb9::GFP embryos to identify motoneurons, we found that 
this protocol yielded roughly 80-90% of GFP-positive neurons. Briefly, isolated neurons were 
incubated at +4°C in 80 μl L-15 medium containing 0.5% bovine serum albumin (BSA) and 2 
µl of an anti-mouse p75 monoclonal antibody (Millipore) for 20 minutes, followed, after 
wash-out, by a 15 minute incubation in 80 µl L-15, 0.5% BSA, 10 µl goat anti-mouse IgG 
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microbeads. The magnetically labeled cells were applied onto a separation column and 
retained using a magnet (Miltenyi Biotec). Following wash-out of the p75 negative fraction 
with L-15, 05% BSA, cell sorting was achieved by removing the magnet. After a final BSA 
cushion, motoneurons were plated onto poly-ornithine laminin-coated wells in Neurobasal 
(Life Technologies) medium containing 2% horse serum, 2% B-27 supplement (Life 
Technologies), 50 µM L-glutamine, 25 µM L-glutamate, 25 µM -mercaptoethanol and a 
cocktail of neurotrophic factors (1 ng/ml BDNF, 100 pg/ml GDNF, and 10 ng/ml CNTF). 
Electrophysiological recordings  
For chloride reversal potential determination of 1 and 7 days in vitro (DIV) motoneurons, 
chloride GABAA current was recorded at 20-22°C with the gramicidin-perforated patch-
clamp technique using an Axopatch 200B amplifier (Dipsi Industrie). The bathing solution 
contained 140 mM TEA-Cl, 3.5 mM MgCl2, 10 mM glucose and 10 mM HEPES, adjusted to 
pH 7.4 with CsOH, and the pipette solution contained 140 mM CsCl, 1.5 mM Mg-ATP, 0.5 
mM Na-GTP, 0.1 mM EGTA and 10 mM HEPES, adjusted to pH 7.35. We determined [Cl
-
]i, 
by adding 50 µg/ml gramicidin A (Sigma-Aldrich) to the pipette solution as described in 
(Pieraut et al., 2007). [Cl
-
]i was calculated according to the Nernst equation: Erev = RT/ZF x 
(log ([Cl
-
]i / [Cl
-
]e), where RT/ZF = 58 mV at room temperature and [Cl
-
]e = 147 mM. 
For electrical activity measurements, 7-8 DIV motoneurons from Slc12a6
+/+
 and Slc12a6
-/-
 
were recorded under whole-cell patch clamp at room temperature in a bathing solution 
containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1.5 mM MgCl2, 10 mM glucose and 10 
mM HEPES, adjusted to pH 7.35. The patch pipette contained 10 mM KCl, 135 mM K-
methane-sulfonate, 1.5 mM Mg-ATP, 0.5 mM Na-GTP, 0.1 mM EGTA and 10 mM HEPES, 
adjusted to pH 7.35. Spontaneous activity of motoneurons was recorded with the loose-patch 
technique after forming a 30-50 MΩ contact between cell membrane and recording electrode. 
The electrode was filled with the extracellular solution. Ouabain, apamin and cadmium 
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chloride were from Sigma. 
RNA extraction and RT-qPCR 
For primary cultures, total mRNA was extracted from roughly 30000 purified embryonic 
motoneurons at 1 or 7 DIV with the RNeasy Mini Kit (Qiagen). For E12.5, P1 and P30 
lumbar spinal cords, the tissues were harvested in RNAlater stabilization
 
buffer (Qiagen). 
Lysis buffer was used for pestle tissue crushing and homogenization by passing the lysate 
through needles. Lysates were then mixed with an equal
 
volume of 70% ethanol, and total 
mRNA was separated from other
 
cellular components on RNeasy minispin columns. The 
eluted
 
mRNA was quantified by spectrophotometry (Nanodrop). Following gDNA wipe out, 
reverse transcription (RT) was performed with 100 ng to 1 µg of mRNA with the Quantitect 
RT kit (Qiagen). The collected cDNA was diluted to 50 ng (culture) or 100 ng (tissue) with 
water and stored at -20°C until further use. Primers were designed with Primers 3.0 software. 
The sequences of the primers used are published in (Lucas et al., 2012). Quantitative PCR 
was performed on 5 or 10 ng cDNA with SYBR Green (Qiagen) for detection and the 
LightCycler system (Roche Diagnostics). After initial activation for 15 min at 95°C, 45 cycles 
of 94°C for 15 s, 60°C for 20 s and 72°C for 35 s were carried out. After PCR amplification, a 
melting curve analysis was carried out to check that the PCR was specific. Polymerase (RNA) 
II polypeptide J (Polr2J) level was used to normalize the amounts of cDNA. ΔCt was 
calculated as the difference
 
between the Ct values, determined with the equation 2
–ΔCt
. 
Immunohistochemistry. 
For spinal cord immunohistochemistry, 4-week-old mice were anaesthetized and perfused 
transcardially with 4% paraformaldehyde. Lumbar spinal cords were removed and post-fixed 
in 4% paraformaldehyde, flash-frozen and cut at a 12-μm thickness. For Na+/K+-ATPase 1 
immunohistochemistry, a citrate buffer antigen retrieval step was performed. The sections 
were then rinsed 5 minutes in PBS and incubated for 2 hours at room temperature in blocking 
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solution (TBLS (10% NaN3), 20% goat serum, 0.3% Triton X-100). This was followed by an 
overnight incubation at +4
o
C with the primary antibodies. Subsequently, sections were 
incubated 1 hour with secondary antibodies and mounted in Mowiol.  
For neuromuscular junction immunohistochemistry, tibialis anterior (TA) muscle sections 
were labeled by immunohistochemistry to allow quantification of neuromuscular innervation 
and endplate morphology as described previously (Bowerman et al., 2012). For ubiquitous 
Slc12a6
-/-
 mice, whole TA muscles were dissected from 4-week-old animals and fixed in 4% 
paraformaldehyde for 15 minutes. Following the removal of connective tissue, the TA 
muscles were incubated with α-bungarotoxin Alexa Fluor 555 conjugate (αBTX)(Life 
Technologies; 1:1000) for 20 minutes at room temperature. The TA muscles were then 
incubated in methanol at -20
o
C for 5 minutes, followed by an overnight incubation at +4
o
C 
with the SV2 and neurofilament antibodies. Incubation with the secondary antibodies was 
performed the following day at room temperature for 1 hour. Finally, two to three thin filets 
per stained TA were cut and mounted in Mowiol. All filets were single sections of the surface 
of the TA muscle. 
For neuron-specific Slc12a6 deletion (nsSlc12a6
∆18/∆18
) mice, NMJ analysis was performed on 
longitudinal frozen sections of 8-week-old animals. TAs were post-fixed in 4% 
paraformaldehyde, flash-frozen and cut at a 10 μm thickness. The sections were then rinsed 5 
minutes in PBS and incubated for 2 hours at room temperature in blocking solution (TBLS 
(10% NaN3), 20% goat serum, 0.3% Triton X-100). This was followed by an overnight 
incubation at 4
o
C with the primary antibodies. Subsequently, sections were incubated 1 hour 
with the secondary antibodies and the αBTX. All washes were done with PBS. 
The primary antibodies used were: goat anti-choline acetyl transferase (ChAT)(1:250; 
AB144P; Millipore), mouse anti-Na
+
/K
+
-ATPase α1 (1:100; DSHB), mouse anti-2H3 
(Neurofilament 165 kDa) (1:250; Developmental Studies Hybridoma Bank), mouse anti-SV2 
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(1:100; Developmental Studies Hybridoma Bank), mouse anti-SMI32 (1:1000; Sternberger 
Monoclonals). The secondary antibodies (Life Technologies) were used at 1:1000.  
Images were taken with a Zeiss confocal microscope. Area of NMJs was determined using 
Image J software (National Institutes of Health, USA). 
Electron microscopy 
TA muscles collected from 4-week-old mice were fixed in a 2% paraformaldehyde/ 0.2% 
glutaraldehyde (Sigma-Aldrich) solution in PBS for 2 hours at 4
o
C. Samples were post-fixed 
overnight at +4°C in 2% PFA and rinsed in PBS. Bundles of about 20 muscle fibers were 
teased out and treated free-floating in solution. Muscle fibers were processed for electron 
microscopy as follows: junctions were identified by detecting nicotinic AChRs with α-
bungarotoxin coupled to biotin (αBTX-biot) using a pre-embedding immunogold method. 
Muscle fibers were incubated in αBTX-biot (10 μg/ml PBS) overnight at 20 °C. After 
washing, muscles were incubated in streptavidin coupled to gold particles (0.8 nm in 
diameter; Nanoprobes; 1:100 in PBS/BSA). The fibers were then washed and post-fixed in 
1% glutaraldehyde. After washing in acetate buffer (0.1 M, pH 7), the signal of the gold 
immunoparticles was increased using a silver enhancement kit (HQ silver; Nanoprobes) for 3 
minutes at room temperature in the dark. Finally, after washing in acetate buffer, sections 
were treated with 1% osmium, dehydrated and embedded in resin. Ultrathin sections were cut, 
stained with lead citrate and examined in a Philips CM120 transmission electron microscope 
(Eindhoven) equipped with a camera (Morada, Soft Imaging System, Olympus). 
Hematoxylin and eosin staining of tibialis anterior sections 
Whole tibialis anterior (TA) were dissected and placed overnight in 4% paraformaldehyde, 
then transferred to 70% ethanol solution. Tissues were embedded in paraffin, cut at a 
thickness of 5 μm, deparaffinized and stained for hematoxylin and eosin. Images were 
acquired with a Leica DMRB. Muscle fiber area was measured using Image J software. 
 11 
Compound muscle action potential recordings 
Subjects were studied with a MEDTRONIC electromyography system (Natus Medical Inc.) at 
CHU de Québec. For ACCPN patients, repetitive nerve stimulations were performed for 3 
different nerves. The spinal accessory nerve was recorded at the trapezius muscle, the facial 
nerve was recorded at the nasalis and the ulnar nerve was recorded at the abductor digiti 
minimi. Studies were performed using constant-current stimulation and a square-wave pulse 
of 0.2 ms duration delivered through a hand-held surface-stimulating electrode (13L36; 
Alpine Biomed) at the frequency of 3Hz. Filters were set at 3 Hz to 5 kHz. A decrement of 
more than 10% between the first and 4
th
 compound muscle action potential (CMAP) was 
considered significant for a neuromuscular transmission defect. 
Statistics 
Data are presented as means ± standard error of the mean (SEM). Data were analyzed by 
Mann-Whitney test for small samples, unpaired two-tailed Student's t‐test, Fisher’s exact test 
or analysis of variance (ANOVA). 
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Results 
Loss of KCC3 results in aberrant pre-synaptic neuromuscular junction terminals 
      To investigate the early cellular and molecular mechanisms contributing to 
neurodegeneration in Slc12a6
-/-
 mice, we used P30 mice, as at this age axonal loss is not yet 
observed while impaired motor function can already be detected (Howard et al., 2002; Byun 
and Delpire, 2007). We found that both Slc12a6
+/+
 and Slc12a6
-/-
 mice displayed the same 
number of motoneurons within the lumbar spinal cord (Fig. 1A, B). However, analysis of 
NMJs within the tibialis anterior (TA) shows that Slc12a6
-/-
 mice display a significant 
increase in incompletely innervated NMJs compared to Slc12a6
+/+ 
littermates (Fig. 1C, D). 
Imaging of wildtype and mutant TAs by electron microscopy (EM) revealed that 
approximately 40% of pre-synaptic NMJ terminals were abnormal, displaying a decreased 
terminal area associated with a large number of partially denervated endplates (Fig. 1E upper 
right, 1F) where, in some cases, the nerve is barely detectable (Fig. 1E lower panels, 1G). 
Indeed, in the latter event, terminal Schwann cell processes completely fill the pre-synaptic 
area (see asterix in Fig. 1E lower right). Thus, our data reveal that KCC3-depleted mice 
display early axonal defects at the NMJ that are not attributable to motoneuron death. 
 
Neuronal-specific KCC3 deletion results in muscle atrophy and aberrant post-synaptic 
neuromuscular junction terminals 
 The loss of innervation led us to investigate the post-synaptic compartment of the 
NMJ. We observed that Slc12a6
-/-
 mice display significantly more morphologically immature 
endplates than Slc12a6
+/+
 littermates (Fig. 2A, B). To address whether these post-synaptic 
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abnormalities were due to KCC3-dependent intrinsic defects within muscle, we analyzed a 
mouse model with a neuron-specific deletion of Slc12a6 exon 18 (nsSlc12a6
Δ18/Δ18
) that 
reproduces the peripheral neuropathy observed in ACCPN patients (Dupre et al., 2003; 
Shekarabi et al., 2012). Similarly to the ubiquitous Slc12a6
-/-
 mice, we find that post-synaptic 
terminals of 8-week old nsSlc12a6
Δ18/Δ18 
display more disorganized morphology than wildtype 
littermates (Fig. 2C). Seeing as our results highlight aberrancies at the interface between nerve 
and skeletal muscle, we set out to determine the impact of loss of KCC3 on skeletal muscle 
parameters. Analysis of TA cross-sections reveals a reduction in myofiber area in Slc12a6
-/-
 
mice (Fig. 2D, E) as well as in nsSlc12a6
Δ18/Δ18
 mice compared to their respective Slc12a6
+/+ 
littermates (Fig. 2F, G). Altogether these data support that a neuronal-specific role for KCC3 
is most likely sufficient for endplate disorganization and amyotrophy. 
 
Patients with Andermann syndrome do not display neuromuscular transmission defects 
 We next sought to support our observations of pre- and post-synaptic NMJ defects in 
ACCPN patients by assessing neuromuscular transmission using measurements of the muscle 
compound potential amplitude. Indeed, recordings of muscle compound action potential, 
CAP, amplitude allows the analysis of denervation-induced amyotrophy which typically leads 
to an overall decrease in CAP amplitude, but not in synaptic gain, therefore keeping a 
constant amplitude during repetitive nerve stimulation. Unlike denervation, end-plate defects 
induce progressive loss of synaptic transmission mirrored by a progressive decrease in CAP 
amplitude. Healthy individuals did not show any muscle fatigability during repetitive motor 
nerve stimulation (Fig. 3A). Patients with myasthenia gravis, a post-synaptic NMJ disorder 
due to the decrease of acetylcholine receptors, showed a gradual reduction of electrical 
muscle response attributed to decreased synaptic integration (Berrih-Aknin et al., 2014)(Fig. 
3B). Consistent with our results obtained in murine models of Andermann syndrome, a strong 
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muscle weakness was also evident in ACCPN patients without signs of muscle fatigability 
under repetitive electrical stimulation (Fig. 3C). Altogether, our data support that presynaptic 
denervation due to loss of neuronal KCC3 contributes to amyotrophy in ACCPN patients. 
 
Developmental expression of cation-chloride cotransporters in spinal cord is unaffected by 
KCC3 loss of function. 
 Having uncovered that defective pre-synaptic NMJ terminals occur early in Slc12a6
-/-
 
mice, we next set out to determine how loss of KCC3 within motoneurons could lead to this 
aberrant synaptic maintenance. As Andermann syndrome is a neurodevelopmental disease, we 
first assessed the pattern of KCC3 expression during spinal cord development. Using 
quantitative PCR (qPCR), we show that KCC3 transcript is expressed as early as embryonic 
day 12.5 (E12.5) and its expression significantly increases during development (P30 
compared to E12.5) (Fig. 4A). KCC3 exists as two distinct isoforms designated as KCC3a 
and KCC3b, with the latter isoform being renal-specific (Hiki et al., 1999; Mount et al., 1999; 
Race et al., 1999). Moreover, an exon 2-deleted form of KCC3a is preferentially expressed in 
the nervous system (Mercado et al., 2005; Le Rouzic et al., 2006; Lucas et al., 2012). We thus 
performed an RT-PCR to compare the expression of KCC3a isoforms in adult spinal cord and 
skeletal muscle. When using a primer set spanning exons 1 and 3 of KCC3a, the alternative 
splicing event was observed in both adult spinal cord and muscle, resulting in bands 
representing both the full-length (FL) and exon-deleted (Δ2) isoforms (Fig. 4B). However, the 
amount of exon 2-deleted transcript was clearly greater in spinal cord than in muscle. Using 
purified cultured motoneurons; we further confirmed the preferential expression of exon 2-
deleted isoform in neuronal cells (Fig. 4B). Indeed, using pan-primers designed to span exons 
13-15 (KCC3ab), we observed a single band, supporting the neuronal specificity of the exon 
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2-deleted KCC3a isoform. There was no detectable transcript with primers specific for 
KCC3b, consistent with its non-neuronal expression.  
 To determine whether KCC3 loss-of-function affects the chloride shift that occurs 
during development, we firstly assessed whether the expression of KCC2 and NKCC1 
transcripts, the main cation-chloride cotransporters involved in [Cl
-
]i maintenance, was 
modified in the spinal cord of Slc12a6
-/-
 mice. We compared transcript levels from E12.5, P1 
and P30 mice and normalized P1 and P30 transcript levels to E12.5 values since KCC2 and 
NKCC1 transcript levels were not significantly different between groups at E12.5 (data not 
shown). Moreover, it was demonstrated that at E12.5 the chloride switch is not yet established 
in spinal motoneurons (Allain et al., 2011). Analysis of KCC2 transcript during development 
of Slc12a6
+/+ 
spinal cord shows the molecular chloride shift signature of an increased 
expression of KCC2 (Rivera et al., 1999) between E12.5 and P1 (Fig. 4C). Further, we find 
that the expression of KCC2 transcript is not significantly different between Slc12a6
+/+ 
and 
Slc12a6
-/-
 mice spinal cords at any time point. More surprisingly, we did not observe the 
expected decrease in the expression of NKCC1 transcript with maturation of Slc12a6
+/+ 
spinal 
cord, but rather a roughly two-fold increase at P30 (Fig. 4D). Importantly, while NKCC1 
levels are similar between Slc12a6
+/+ 
and Slc12a6
-/-
 mice at E12.5 and P1, there is a further 
increase of NKCC1 transcript in P30 mutant mice compared to aged-matched controls. Seeing 
as NKCC1 plays an opposing role to that of KCC3 (inward chloride transport instead of 
outward), the increased expression of NKCC1 in KCC3-depleted mice may simply result 
from a non-specific compensatory mechanism or, alternatively, stem from other non-neuronal 
cell types within the spinal cord (Hubner et al., 2001; Yan et al., 2001). Nevertheless, we have 
identified on one hand a developmental increased transcript expression of all three cation-
chloride cotransporters (KCC3, KCC2, NKCC1) in the spinal cord and on the other hand, an 
abnormal expression of NKCC1 in the spinal cord of P30 Slc12a6
-/-
 mice. 
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Developmental chloride shift in primary motoneuron cultures is unaffected by KCC3 loss-of-
function 
 Since the spinal cord is a heterogeneous mixture of cells, we set out to functionally 
assess the impact of KCC3 loss-of-function on [Cl
-
]i maintenance in primary cultures of 
purified motoneurons. To isolate motoneurons, we performed primary culture from E12.5 
embryos, before the first wave of programmed death (Raoul et al., 1999) which allows the 
generation of enough material for combined molecular analyses and electrophysiological 
measurements. We first investigated the effect of KCC3 depletion on KCC2 and NKCC1 
transcript expression during in vitro maturation of motoneurons isolated from E12.5 embryos 
between 1 and 7 days in vitro (DIV) (Fig. 4E). Our qPCR analysis reveals that NKCC1 
transcripts are decreased while KCC2 transcripts are increased during normal maturation of 
Slc12a6
+/+ 
motoneurons. In 7 DIV Slc12a6
-/-
 motoneurons, NKCC1 and KCC2 followed the 
same expression profiles than Slc12a6
+/+ 
motoneurons, albeit with a significant reduction in 
the temporal increase of KCC2 transcript compared to control cells. Interestingly, the in vitro 
expression changes observed in motoneuron cation-chloride cotransporters between 1 and 7 
DIV are qualitatively similar to those between E12.5 and P1 spinal cord (Fig. 4C, D).  
 The increase in KCC2 transcript together with the decrease in NKCC1 transcript 
observed between 1 and 7 DIV suggest that a chloride shift probably occurs during the 
maturation of cultured motoneurons. We therefore recorded the chloride reversal potential of 
GABA current (EGABA-A) with the gramicidin-perforated patch-clamp method to determine if 
loss of KCC3 would influence chloride balance in motoneurons (Fig.4F, G). Consistent with 
the temporal differential expression of KCC2 and NKCC1 transcripts in motoneurons, EGABA-
A showed a 22 mV hyperpolarization from -56 ± 3 mV (n = 12) at 1 DIV to -78 ± 3 mV (n = 
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10) at 7 DIV in Slc12a6
+/+ 
motoneurons. In Slc12a6
-/-
 motoneurons, in vitro maturation still 
induced a 20 mV shift of EGABA-A from -62 ± 3 mV (n = 10) at 1 DIV to -82 ± 4 mV (n = 8) at 
7 DIV (Fig.4G). The corresponding [Cl
-
]i, calculated with the Nernst equation, showed this 
concentration to be 17 ± 2 mM and 13 ± 2 mM at 1 DIV, decreasing to 7 ± 1 mM and 6 ± 1 
mM, at 7 DIV, in Slc12a6
+/+ 
and Slc12a6
-/-
 motoneurons, respectively (P < 0.001 between 1 
and 7 DIV for both genotypes, t-test). Thus, loss of KCC3 does not alter the [Cl
-
]i of 1 and 7 
DIV motoneurons, suggesting that [Cl
-
]i
 
-dependent excitability is not affected in Slc12a6
-/-
 
motoneurons. 
 
Loss of KCC3 alters firing properties of motoneurons 
 Besides chloride regulation, KCC3 activity is known to induce changes in intracellular 
K
+
 concentration, which in turn could modify the Na
+
/K
+
 ATPase (NKA) activity as well as 
other related ionic channels (Fujii et al., 2010; Adragna et al., 2015). Therefore, we compared 
the electrical properties of Slc12a6
+/+
 and Slc12a6
-/-
 motoneurons at 7-8 DIV, an in vitro time 
point at which we have previously shown motoneuron cultures reach electrical maturation 
(Camu et al., 2014). Due to the lack of neuromodulatory control, primary cultures allow the 
analysis of the primary range of motoneuron firing properties exclusively (Brownstone, 2006; 
Heckman et al., 2009). We found no significant differences in whole cell capacitance (54.3 ± 
3.3 pF, n = 13 for Slc12a6
+/+
 motoneurons and 58.0 ± 3.7 pF, n = 19 for Slc12a6
-/-
 
motoneurons, t-test) and in input resistance (218 ± 16 MΩ and 188 ± 17 MΩ for Slc12a6+/+ 
and Slc12a6
-/-
 motoneurons, respectively, t-test). We also saw no differences in resting 
membrane potential, action potential amplitude and duration (Fig. 5A-C). Further, 
motoneurons from both genotypes were able to fire repetitive action potentials under 
application of a 500 ms depolarizing current (Fig. 5D) and their frequency-current 
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relationships were similar (Fig. 5E). However, a salient feature of KCC3 deletion was the 
progressive depolarization of the amplitude of the after hyperpolarization (AHP) of each 
action potential during a train of activity, while it remained constant in Slc12a6
+/+
 
motoneuron (Fig. 5D, F). Moreover, the appearance of hyperpolarization following a train of 
action potentials, known as post-tetanic hyperpolarization (PTH), was significantly reduced in 
Slc12a6
-/- 
motoneurons (Fig. 5D, G).  
 As the cation-chloride co-transporters are electroneutral, the depolarization of plateau 
potential observed in Slc12a6
-/-
 motoneurons cannot be due to the loss of KCC3 activity per 
se and is most likely the result of a disturbed electrogenic mechanism. The ionic currents 
governing plateau potential of motoneurons in primary culture and potentially linked to KCC3 
activity are the K
+
 and Cl
-
 channels and the NKA (del Negro et al., 1999; Brownstone, 2006). 
Due to the lack of differences in action potentials duration, voltage-dependent K
+
 currents 
were excluded from the candidates. Analysis of the effects of Ca
2+
-activated K
+
 (BK and SK) 
currents using either CdCl2, a non-specific inhibitor of voltage-gated Ca
2+
 currents (Fig. 6A, 
B) or apamin, a specific SK channel inhibitor (Fig. 6C, D), shows an increase in firing 
frequency without significant modification of plateau potential of wildtype motoneurons, thus 
ruling out their contribution to the depolarization observed in Slc12a6
-/-
 motoneuron. There is 
no report of voltage-gated Cl
-
 currents being expressed in motoneurons, and the effects of 
CdCl2 rule out the contribution of a Ca
2+
 activated Cl
-
 current. We next analyzed the effects of 
ouabain, an inhibitor of NKA on motoneuron electrical activity. At 3 and 10 µM, ouabain had 
no effects on electrical activity. At 100 μM, it induced a 4 mV shift of the plateau potential 
towards more depolarized values during repetitive activity (Fig. 6E, F). Although the RMP 
was not significantly modified (-64 ± 2 mV in control condition and -59 ± 6 mV 2 minutes 
after ouabain application, n = 7), the PTH decreased from -1.16 ± 0.27 mV to -0.22 ± 0.25 
mV, n = 7, p = 0.02 (Fig. 6G). We also observed that, under extracellular loose patch-clamp, 
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at least 100 µM ouabain were necessary to increase motoneuron spontaneous firing frequency 
(not shown). 
Altogether, our results suggest that loss of KCC3 promotes the reduction of an activity-
dependent hyperpolarizing current that could be related to a progressive decrease in NKA 
pump current. 
 
Motoneuron excitability contributes to NMJ denervation in Slc12a6
-/-
 mice 
 Having established the potential neuronal origin of NMJ denervation and an activity-
dependent reduction in hyperpolarizing current, we aimed to verify whether a causative 
relationship could exist between Slc12a6
-/-
 motoneuron excitability and innervation of NMJs, 
as previously reported in early stages of various neuromuscular and neurodegenerative 
diseases (Kanai et al., 2006; Liu et al., 2015). To decrease motoneuron electrical activity in 
vivo, we used carbamazepine (CBZ), a clinically-approved molecule for the treatment of 
hyperexcitability-related disorders such as epilepsy or neuropathic pain (Bialer, 2012). We 
first deciphered the effects of CBZ on motoneurons by analyzing its effects on 7 DIV 
Hb9::GFP motoneurons isolated from the ventral horn spinal cord of E12.5 embryos without 
purification steps, which allows the recording of a synaptically-driven spontaneous activity 
(Fig. 7A, B). Acute application of 10 µM CBZ did not modify spontaneous motoneuron 
activity while, at 100 µM, CBZ decreased the frequency of spontaneous motoneuron activity 
without apparent reduction in spike amplitude. 
 Having established that CBZ decreases spontaneous motoneuron activity without 
effects on spike amplitude, its effect on NMJ innervation was evaluated by daily 
intraperitoneal injections to Slc12a6
-/-
 mice from P10 to P30 (0.025 mg/g). By analyzing TA 
muscles from vehicle- and CBZ-treated Slc12a6
-/-
 mice, we found that CBZ-treated Slc12a6
-/-
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mice display significantly more fully innervated NMJs than vehicle-treated Slc12a6
-/-
 mice 
(Fig. 7C, D). In addition, nerve terminals of partially innervated CBZ-treated NMJs appeared 
to cover a greater area of the endplate than vehicle-treated NMJs (Fig. 7C, arrows).  
These data, together with the role of NKA pump in maintenance of the plateau potential of 
motoneurons, led us to investigate further the expression of NKA in large α-motoneurons of 
the ventral region of the spinal cord. As previously reported (Edwards et al., 2013), the 
specific membrane expression of NKA α1 subunit is a marker of large cholinergic 
motoneurons (Fig. 7E). Strikingly, NKA α1 displays a non-uniform pattern around the cell 
body perimeter of Slc12a6
-/-
 motoneurons as opposed to the homogeneous pattern in wildtype 
motoneurons (Fig. 7E). To quantify this uneven localization of NKA α1 around the cell 
perimeter of Slc12a6
-/-
 motoneurons, we measured the NKA α1 staining intensity along the 
membrane and used the standard deviation (SD) as a read-out for heterogeneous expression. 
Indeed, a small SD is indicative of a uniform staining pattern while a high SD suggests 
uneven distribution along cell body perimeter. Our analysis shows that the average SD of 
NKA α1 staining intensity along the membrane is significantly greater in Slc12a6-/- 
motoneurons than in Slc12a6
+/+ 
cells (Fig. 7F, left). Importantly, in vivo CBZ treatment 
restores NKA α1 staining intensity along the membrane of Slc12a6-/- motoneurons (Fig. 7E-F, 
right). 
Modifications in NKA α1 expression in motoneurons together with the effects of the activity-
targeting drug CBZ on NMJ innervation provide strong support to a contribution of 
motoneuron activity to the neurodegenerative events that occur in Slc12a6
-/-
 animals. 
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Discussion 
Our results reveal the role of electrical activity in the process of NMJ denervation and 
subsequent neurodegeneration in Andermann syndrome. We found that loss of KCC3 
function is associated with an abnormal intrinsic neuronal electrical activity. Notably, we 
show that pharmacologically decreasing the firing frequency of Slc12a6
-/- 
motoneurons 
partially rescues innervation at the NMJ. 
Our study shows for the first time that prior to axonal degeneration, significant pre- and post-
synaptic NMJ defects accompany skeletal myofiber atrophy, which can account for the early 
locomotor abnormalities observed in young Slc12a6
-/-
 mice (Howard et al., 2002). This 
observation suggests that early denervation could as well contribute to axon swelling and 
myelin destruction, as described in nerve injury models (Vargas and Barres, 2007) and 
neurodegenerative diseases such as amyotrophic lateral sclerosis, in which the earliest pre-
symptomatic functional and pathological changes observed occur distally in axons and at the 
NMJ (Moloney et al., 2014). The NMJ is a tri-partite synapse, composed of the skeletal 
muscle fiber, the motoneuron terminal and several terminal Schwann cells and any 
disturbance in these elements can induce denervation. The role of excitability in 
neurodegenerative diseases is unclear and, depending on the cellular pathological context, 
motoneuron hyperexcitability either promotes NMJ denervation (Ruegsegger et al., 2015) or 
protects against it (Saxena et al., 2013). Here, using the neuron-specific Slc12a6
-/-
 mice, we 
provide evidence that aberrant motoneuron activity is responsible for NMJ denervation at the 
TA muscle and that by decreasing motoneuron firing frequency via CBZ, we could slow 
down the denervation process in Slc12a6
-/-
 mice. Together, our data suggest that KCC3-
dependent excitability is detrimental to NMJ maintenance, which is consistent with the 
absence of NMJ neurotransmission defects in ACCPN patients. 
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Several possibilities could account for the neuronal specific effects of KCC3. First, the 
expression of the short KCC3a isoform is enriched in spinal cord and motoneurons compared 
to skeletal muscle. Nothing is known about the function and molecular interactions of this 
isoform and it will be of great interest to further decipher its role in the nervous system. 
Second, the neuronal effects could be related to electrical activity. We show that in the spinal 
cord and motoneurons, the chloride shift and the increased expression of KCC2 still occur in 
the absence of KCC3, suggesting that the molecular mechanisms that regulate inhibitory 
neurotransmission correctly take place in Slc12a6
-/-
 mice. At 7 DIV, roughly 20 mV more 
depolarized values of RMP compared to EGABA-A confirm similar hyperpolarizing effects of 
GABAergic transmission in electrically mature motoneurons of both genotypes as reported in 
spinal cord developmental studies (Delpy et al., 2008; Stil et al., 2009). Quantitatively, there 
is a factor of 10 in the fold change in KCC2 transcripts expression in spinal cord compared to 
isolated motoneurons, which could be related to the presence of interneurons in spinal cord 
and suggests that regulation of KCC2 expression is more moderate in motoneurons than in 
interneurons or dorsal horn. KCC2 protein expression increases until the end of the first post-
natal week both in ventral and dorsal horn (Stil et al., 2009) and the chloride switch in rat 
dorsal horn occurs at P0-P1 in 60 % of neurons and is completed by P7 (Baccei and 
Fitzgerald, 2004; Cordero-Erausquin et al., 2005). Despite discrepancies between transcript 
and protein levels between spinal cord and primary motoneuron culture, chloride extrusion 
capacity in isolated motoneurons is quite efficient and could also be related to other buffering 
system. While extrapolating data from embryonic cultured motoneurons to adult neurons in 
vivo comes with cabeats, the resting [Cl
-
]i in 7DIV cultured E12.5 motoneurons is not 
different from that found in mature cells (Delpy et al., 2008; Stil et al., 2009) and thus allows 
for some cautious inferences. The increase in NKCC1 transcript at a later stage in spinal cord 
is probably related to non-neuronal cells (Stil et al., 2009). Its overexpression in Slc12a6
-/-
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spinal cords needs further investigation at protein and cellular levels. Altogether, our results 
rule out a direct role for KCC3 in the control of chloride-driven motoneuron electrical 
activity. 
Analysis of firing properties of purified motoneurons at 8 DIV shows that frequency-current 
relationship reaches a plateau level around 20-30 Hz within 150 pA without changes in slope 
following a higher current amplitude. Most studies in spinal motoneurons, performed on P8-
P15 slices, describe two levels of firing: a primary range at a maximal 40 Hz attributed to 
intrinsic motoneuron properties followed by a secondary range attributed to ionotropic and 
neuromodulatory influences (Brownstone, 2006; Heckman et al., 2009). Contrary to in vivo 
recordings, the absence of synaptic inputs and descending pathways in the highly purified 
motoneuron cultures prevents recordings of the secondary range of firing. Comparison of 
motoneuron electrical properties with in situ slice recordings shows that the major difference 
with post-natal motoneurons concerns values of input resistance, which are higher in primary 
cultures, accounting for their lower threshold current amplitude (Carrascal et al., 2005). More 
recently, recordings from adult mouse slices show that input resistance is closer to primary 
cultures than post-natal slices, which account for similar relationship between current 
amplitude and corresponding frequency (Mitra and Brownstone, 2012). In addition to the f-I 
relation, we show that apamin is able to increase firing frequency, as reported in post-natal 
P9-P15 spinal cord slices recordings (Miles et al., 2007), supporting functional modulatory 
mechanisms in primary cultures. Using purified motoneurons, we demonstrate that KCC3 
deletion does not modify the f-I relation, but induces a progressive depolarization of plateau 
potential during rhythmic activity. Among the candidates tested, Ca
2+
 activated K
+
 currents 
and the NKA, only inhibition of NKA was able to induce a depolarization of the plateau 
potential suggesting that ionic unbalance progressively takes place during maintained activity 
in the absence of KCC3. In addition, we show in spinal cord that plasma membrane 
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expression of the 1-subunit of NKA is modified in the absence of functional KCC3. 
Interestingly, the expression of NKA α subunits in spinal cord is not pan-motoneuronal as two 
recent studies show that the α1 subunit is a marker of a subpopulation of large α-motoneurons 
including the fast resistant (FR) and the slow (S) motoneurons, while the α3 subunit is mainly 
a marker of the fast fatigable (FF) α-motoneurons and the small γ-motoneurons innervating 
intrafusal muscle fibers (Edwards et al., 2013; Ruegsegger et al., 2015). The NKA is an 
electrogenic ion pump essential for maintenance of cellular electrochemical gradients 
(Kaplan, 2002) and activity-dependent changes in NKA pump can alter the hyperpolarizing 
pump current (Scuri et al., 2002; Kim et al., 2007). Although we cannot state whether activity 
of the pump is directly affected by KCC3 loss of function, our results are in line with studies 
showing that KCC3 hyperactivity increases NKA activity (Adragna et al., 2015) while KCC3 
inhibition has the inverse effect (Fujii et al., 2008). Moreover, decreased NKA activity 
induces NMJ denervation (Ruegsegger et al., 2015). Remarkably, by decreasing motoneuron 
firing frequency, CBZ restore Na
+
K
+
-ATPase α1 localization. While membrane pattern of the 
pump is fully restored, CBZ treatment cannot promote full NMJ reinnervation suggesting that 
its effects slow denervation process and/or that denervation is not reversible. These data also 
suggest that the membrane redistribution of the NKA α1-subunit might be a consequence of 
the hyperexcitable state induced by the decreased activity of the pump in Slc12a6
-/-
 
motoneurons, an observation that needs further investigation on the cellular mechanisms 
linking protein activity and localization. Additional mechanisms may also contribute to the 
impaired locomotor capacities described in Slc12a6
-/-
 mice. Indeed, it has recently been 
demonstrated that the selective deletion of Slc12a6 in parvalbumin-positive proprioceptive 
neurons is sufficient to induce locomotor defects (Ding and Delpire, 2014), which could be 
linked to an increased pre-synaptic inhibition of a subset of sensory neurons (Lucas et al., 
2012). 
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Conclusion 
Overall, our results highlight novel pathological hallmarks and molecular effectors within the 
motor circuitry of Andermann syndrome. Of utmost importance is the targeting of 
motoneuron excitability with CBZ to maintain some innervation in Slc12a6
-/-
 mice. These 
findings have major clinical implications as they bring forward novel symptomatic and 
molecular therapeutic targets for the treatment and clinical management of ACCPN patients. 
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Figure legends 
Figure 1. Neuromuscular junction denervation is an early marker of Slc12a6
-/-
 associated 
neuropathy. (A) Representative images of lumbar spinal cord cross-sections from Slc12a6
+/+
 
and Slc12a6
-/-
 stained with SMI32 antibody to morphologically identify the large 
motoneurons within the ventral horn region. Scale bar = 100 μm. (B) Counts of SMI32-
labelled large motoneuron cell bodies per section of ventral lumbar spinal cords show no 
difference between Slc12a6
+/+
 (7.28 ± 0.81 motoneurons/section, n = 34 sections; N = 3 mice) 
and Slc12a6
-/-
 (7.00 ± 0.64 motoneurons/section, n = 54 sections; N = 4 mice; non-significant, 
ns; Student's t‐test). Scale bar, 100 µm. (C) Images of complete and partially innervated NMJ 
immunolabeled with neurofilament (NF; green) and synaptic vesicle (SV2; green) antibodies 
to visualize the nerve terminal and with alpha-bungarotoxin (αBTX; red) to identify the NMJ 
endplate. (D) Analysis of NMJs in whole tibialis anterior (TA) muscles shows a 25 % 
increase in incomplete innervation in P30 Slc12a6
-/-
 mice ( 0.76 ± 0.76 %, n = 112 and 18.96 
± 5.24 %, n = 157 endplates from Slc12a6
+/+
 and Slc12a6
-/-
, respectively; N = 4 TA muscles 
from 4 mice for each condition; *P < 0.05, Student's t‐test). Scale bar: 5 µm. (E-G) Electron 
micrographs of NMJs from the TA muscle of Slc12a6
+/+
 and Slc12a6
-/-
 mice (E). Upper left 
panel shows a typical NMJ in Slc12a6
+/+
 where the nerve terminal (T) faces a muscle cell 
(MC) and is capped by terminal Schwann cell (TCS) processes (arrows). In Slc12a6
-/-
 muscle, 
smaller NMJs are observed (upper right panel) and display shrinked terminals capped with 
TSC processes (lower left panel) or are even devoid of a nerve terminal (asterisk in lower 
right panel). (F) NMJs of Slc12a6
-/-
 mice (1.17 ± 0.17 µm2, n = 38) are smaller than 
Slc12a6
+/+
 mice (2.52 ± 0.31 µm2, n = 43; ***P < 0.001; Student's t‐test). Scale bars: 500 
nm. (G) Evaluation of the innervation status of NMJs shows a greater proportion of Slc12a6
-/-
 
NMJs with partial innervation of the terminal area (42.05 ± 17.05 %, n = 38) compared to 
Slc12a6
+/+
 NMJs (100 % innervation, n = 43; ***P < 0.001; Fisher’s exact test). N = 2 mice 
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for each condition; n = 38 terminals for Slc12a6
-/-
 mice and n = 43 terminals for Slc12a6
+/+
 
mice. 
 
Figure 2. Pre-synaptic defects contribute to post-synaptic neuromuscular junction 
disorganization and skeletal muscle atrophy in KCC3-deleted mice. (A-C) Morphological 
analysis of mature pretzel-like and disorganized (perforations with bright lines or plaque-like) 
NMJ endplates from TA muscles identified with -Bungarotoxin-555 (A) shows more 
disorganized endplates in Slc12a6
-/-
 mice ( (B) and in neuron-specific nsSlc12a6
Δ18/Δ18
 mice 
(C) than in Slc12a6
+/+
 mice. (7.42 ± 2.39 %, n = 167 and 37.88 ± 3.53 %, n = 157 endplates 
for Slc12a6
+/+
 and Slc12a6
-/-
, respectively; N = 5 TA in (B) and 22.986 ± 2.85 %, n = 78 and 
42.31 ± 6.41 %, n = 84 endplates for Slc12a6
+/+
 and Slc12a6
∆18/∆18
, respectively; N = 3 for 
each condition in (C); **P < 0.01; Fisher’s exact test); scale bar: 5 µm. (D,E) Myofibers of 
Slc12a6
-/-
 mice have smaller area (383 ± 21 µm2, n = 3125 myofibers) than their litternate 
Slc12a6
+/+
 mice (553 ± 48 µm2, n = 2190 myofibers) and (F,G) neuron-specific 
nsSlc12a6
Δ18/Δ18
 mice have smaller area compared to their littermate Slc12a6
+/+
 mice (540 ± 
69 µm2, n = 1008 myofibers for nsSlc12a6
+/+ 
and 247 ± 22 µm2, n = 2507 myofibers for 
nsSlc12a6
Δ18/Δ18
); N = 3 TA for each group; *P < 0.05 Student's t‐test). Scale bars: 50 μm. 
Cross-sections of hematoxylin and eosin coloration of paraffin-embedded TA muscles. 
 
Figure 3. Neuromuscular transmission is unaffected in ACCPN patient. (A-C) There is no 
evidence of a decrement in amplitude of muscle compound action potential (CAP) with time 
in a control patient (A). A gravis myasthenia patient served as a positive control for 
neuromuscular transmission defects and is characterized by a significant (> 10%) decrease in 
the CAP amplitude due to the decrease of post-synaptic acetylcholine receptors (B). 
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Amplitude of motor CAP is severely decreased in ACCPN patients (basal motor potential is 
1.0 ± 0.1 mV, n =2 compared with 9.1 ± 1.1 mV in 3 healthy patients; 35, 41 and 61 years 
old) and shows no significant decrease with repetitive stimulation (at 3 Hz motor potential 
amplitude remains constant 1.0 ± 0.1 mV in ACCPN patients and 9.1 ± 1.1 mV in the healthy 
patients) (C). Table shows the clinical evaluation of the two ACCPN patients. 
 
 
Figure 4. Deletion of Slc12a6 does not affect the developmental chloride shift. (A) 
Quantitative PCR of KCC3 transcript expression in the spinal cord at embryonic day 12.5 
(E12.5), postnatal day 1 (P1), P15 and young adult (P30) (n = 3 for each group) shows a 
significant upregulation of KCC3 transcript during spinal cord development (one-way 
ANOVA; *P < 0.05). (B) Representative RT-PCRs showing the presence of KCC3 transcript 
isoforms in P30 adult spinal cord (SC), P15 and P30 tibialis anterior muscle and cultured 
motoneurons at 7 days in vitro (DIV). Spinal cord and motoneurons show preferential 
expression of the exon 2-deleted KCC3a transcript isoform while both KCC3a transcript 
isoforms (FL KCC3a = full length KCC3a; Δ2-KCC3a = exon-2-deleted) are similarly 
expressed within muscle. KCC3b transcript is not expressed in motoneurons. (C) Quantitative 
PCR of KCC2 and (D) NKCC1 transcripts was performed on the lumbar spinal cord of E12.5, 
P1 and P30 Slc12a6
+/+
 and Slc12a6
-/-
 mice and expressed relative to E12.5. For KCC2 at P1: 
15.9 ± 2.0 fold increase and 16.5 ± 2.3 fold increase from Slc12a6
+/+
 and Slc12a6
-/-
, 
respectively; at P30: 22.2 ± 1.6 fold increase and 26.5 ± 6.4 fold increase from Slc12a6
+/+
 and 
Slc12a6
-/-
, respectively. n = 3 cultures for each group. For NKCC1 at P1: 1.65 ± 1.75 fold 
decrease and 0.36 ± 1.08 fold decrease from Slc12a6
+/+
 and Slc12a6
-/-
, respectively; at P30: 
7.5 ± 1.1 fold increase and 15.4 ± 3.6 fold increase from Slc12a6
+/+
 and Slc12a6
-/-
, 
respectively. n = 3 cultures for each group. While loss of Slc12a6 does not influence the 
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expression of KCC2 transcript, we find a significant upregulation of NKCC1 transcript during 
the developmental of Slc12a6
-/-
 spinal cord. The mRNA levels of each cation-chloride 
cotransporter were normalized to the relative expression of Polr2j, a housekeeping control 
gene. mRNA fold increase at different time points was obtained by dividing their expression 
by the values obtained at E12.5, which were not significantly different between groups (two-
way ANOVA; *P < 0.05). (E) Quantitative PCR was performed on enriched spinal 
motoneuron cultures isolated from E12.5 Slc12a6
+/+
 and Slc12a6
-/-
 spinal cord at 1 DIV and 7 
DIV (for NKCC1: 1.45 ± 0.06 fold decrease, n = 4 and 1.73 ± 0.40, n = 3 from Slc12a6
+/+
 and 
Slc12a6
-/-
, respectively. For KCC2: 2.6 ± 0.2 fold increase, n = 6 and 1.6 ± 0.4, n = 3 from 
Slc12a6
+/+
 and Slc12a6
-/-
, respectively). Loss of KCC3 does not affect NKCC1 transcript 
levels while there is a significant 40 % decrease of KCC2 transcript during in vitro maturation 
of primary motoneurons. mRNA expression levels were first normalized to the relative 
expression level of Polr2j. mRNA changes for KCC2 and NKCC1 at 1 DIV were not 
different between each group (for KCC2: normalized expression was 1.3 ± 0.1 and 1.2 ± 0.3 
for Slc12a6
+/+
 and Slc12a6
-/-
, respectively and for NKCC1: normalized expression was 1.2 ± 
0.1 and 1.1 ± 0.2 for Slc12a6
+/+
 and Slc12a6
-/-
, respectively). Variation in gene expression 
during in vitro maturation was obtained by plotting the 7 DIV mRNA/1 DIV mRNA for each 
gene (two-way ANOVA). (F) Gramicidin-perforated patch clamp recordings showing 
currents evoked by the brief application of 50 µM muscimol on a wild type motoneuron at 7 
DIV. Ramp protocols from -80 mV to +40 mV were applied every 5 seconds for measurement 
of the reversal potential, EGABA-A, of the chloride current. (G) Slc12a6 deletion does not 
modify the EGABA-A of 1 DIV motoneurons and does not prevent the hyperpolarizing shift in 
EGABA-A observed in 7 DIV motoneurons. The number of motoneurons analyzed is indicated 
in parentheses above their respective column (two-way ANOVA; **P < 0.01; ***P < 0.001). 
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Figure 5. KCC3 contributes to plateau potential during sustained firing of motoneuron. (A) 
Representative traces of action potential (AP) recordings in 7 DIV Slc12a6
+/+
 (left) and 
Slc12a6
-/-
 motoneurons (right). (B) Resting membrane potential RMP (-59.6 ± 2.0 mV and -
58.8 ± 1.5 mV in Slc12a6
+/+
 and Slc12a6
-/-
 motoneurons, respectively), the peak amplitude of 
the AP (48.1 ± 2.9 mV and 43.9 ± 1.7 mV in Slc12a6
+/+
 and Slc12a6
-/-
 motoneurons, 
respectively) and (C) the duration of the AP (1.10 ± 0.08 ms and 0.94 ± 0.04 ms in Slc12a6
+/+
 
and Slc12a6
-/-
 motoneurons, respectively) are not significantly different between the two 
genotypes. The number of motoneurons is indicated in brackets. (two-way ANOVA; ns, not 
significant). (D) Representative current-clamp recordings of repetitive firing in Slc12a6
+/+
 
and Slc12a6
-/-
 motoneurons elicited by supra-threshold (110 pA) current injection (500 ms 
duration). (E) Spike frequency versus injected current shows no significant differences 
between the two genotypes (multiple t-tests); the mean action potentials number at 110 pA 
was 10.1 ± 0.8 (range from 3-14) and 10.4 ± 0.7 (range 2-16) in Slc12a6
+/+
 and Slc12a6
-/-
 
motoneurons, respectively. (F) Amplitude of the peak after hyperpolarization of each action 
potential during a repetitive activity (plateau AHP) induced with a 110 pA current injection 
plotted versus each of action potential (i.e. with time). This relationships shows that the 
plateau potential remains constant in Slc12a6
+/+
 motoneurons while it significantly 
depolarizes in Slc12a6
-/-
 motoneurons (multiple t-test; *P < 0.05, **P < 0.01). (G) Peak 
amplitude of the post-tetanic hyperpolarization, PTH in (D) was measured at the end of the 
500 ms action potential train, following a supra-threshold current injection (110 pA). PTH is 
significantly decreased in Slc12a6
-/-
 motoneurons (- 5.2 ± 0.6 mV, n = 13 and -2.8 ± 0.6, n = 
19 from Slc12a6
+/+
 and Slc12a6
-/-
 motoneurons, respectively; t-test; *P < 0.05).  
 
Figure 6. Pharmacological characterization of ionic currents involved in plateau potential 
maintenance in 7 DIV Slc12a6
+/+
 motoneurons. (A) Inhibition of voltage-gated Ca
2+
 currents 
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with 100 µM CdCl2 induces an increase in motoneuron firing frequency from 14.0 ± 3.2 Hz to 
20.5 ± 2.9 Hz without significant change in plateau potential (B) (n = 4 motoneurons, p < 
0.05, paired experiments). (C,D) Specific inhibition of the Ca
2+
-activated K
+
 current, SK 
channels, with apamin increases firing frequency from 11.7 ± 1.3 Hz to 17.3 ± 1.4 Hz by 
reducing the slope of the slow depolarization following a spike without changing the value of 
plateau potential (n = 7 motoneurons, p < 0.001, paired experiments). (E) Inhibition of the 
Na
+
-K
+
 ATPase with 100 µM ouabain induces a significant depolarization of the plateau 
potential (n = 7, paired test, ** p < 0.01), without changes in firing frequency (21.7 ± 1.9 Hz 
and 22.6 ± 1.8 Hz before and after ouabain, respectively; n = 7, P = 0.7) (F). (G) The 
amplitude of PTH is decreased from -1.16 ± 0.27 mV to -0.22 ± 0.25 mV following ouabain 
treatment (n = 7, paired test, * p < 0.05).  
 
Figure 7. Motoneuron excitability contributes to Slc12a6
-/-
 neuromuscular junction 
innervation. (A) On line recordings of in vitro spontaneous electrical activity of Hb9::GFP 
motoneurons before and after cumulative application of 10 µM and 100 µM CBZ. (B) At 100 
µM, CBZ induces a 60% decrease in firing frequency (n = 3; **P < 0.01; one way ANOVA). 
(C) Images of P30 NMJs from vehicle- and CBZ-treated Slc12a6
-/-
 mice showing full and 
partial innervation of whole TA muscles. Arrowheads indicate incomplete NMJ innervation. 
Scale bar: 50 μm. (D) Quantification of innervation status confirms that CBZ treatment 
increases the number of innervated NMJs in Slc12a6
-/-
 mice (60.9 ± 3.2 % of innervation) 
compared to vehicle-treated Slc12a6
-/-
, (49.2 ± 1.7 % of innervation) but does not totally 
rescue the control phenotype (99 ± 1 % of innervation) (260, 710 and 260 endplates for 
Slc12a6
+/+
, vehicle-treated Slc12a6
-/-
 and CBZ-treated Slc12a6
-/-
 respectively; N = 3 mice for 
each group, **P < 0.01; ***P < 0.001; one-way ANOVA). (E) Spinal cord cross-sections of 
P30 Slc12a6
+/+
, vehicle and CBZ-treated Slc12a6
-/-
 mice were immunolabeled with the 
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Na
+
/K
+
-ATPase (NKA) α1 antibody and the motoneuron marker choline acetyl transferase 
(ChAT). Scale bar, 25 µm. (F) Quantification of the standard deviation (SD) of NKA α1 
staining intensity along motoneuron membrane perimeter shows a significantly greater 
uneven distribution of NKA α1 in Slc12a6-/- spinal cord motoneurons (11.35 ± 0.36 SD, n = 
140) compared to Slc12a6
+/+
 motoneurons (8.56 ± 0.24 SD, n = 156) (N = 3 mice for each 
group, *** P < 0.001; t-test; left panel). In vivo treatment with CBZ restores NKA α1 staining 
intensity of motoneurons to control levels (8.47 ± 0.39 SD, n = 124, in Slc12a6
+/+
 
motoneurons; 12.34 ± 0.49 SD, n = 71, in vehicle-treated Slc12a6
-/-
 mice.compared to 8.03 ± 
0.30 SD, n = 137, in CBZ-treated Slc12a6
-/-
 mice; one-way ANOVA; right panel. N = 3 mice 
for each group). 
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